Optimal surgical cytoreduction continues to be an important prognostic variable in patients with ovarian cancer independent of p53 mutational status. Among patients with suboptimal cytoreduction a p53 mutation may offer a survival advantage.


P53, cytoreductive surgery, survival, ovarian cancer

Total Pages



Copyright © David Engle, Hubert Fornalik, Traci Neff, Anna Button, K Collins, Amina Ahmed, David Bender, Susan Lutgendorf, Michael J. Goodheart, 2011

Creative Commons License

This work is licensed under a Creative Commons Attribution 3.0 License.